| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/27/2007 | CN1985915A Chinese medicine for treating diabetes complication |
| 06/27/2007 | CN1985909A Medicine for hyperlipemia and its production process |
| 06/27/2007 | CN1985908A Blood vessel cleaning tea and its making process |
| 06/27/2007 | CN1985886A Medicine composition for treating diabetes |
| 06/27/2007 | CN1985877A Astragalus extract and its medicine use |
| 06/27/2007 | CN1985855A Ginkgo health vinegar recipe and preparing method |
| 06/27/2007 | CN1985850A Oral medicine composition for replenishing Ca, Mg and Fe and its preparing method and use |
| 06/27/2007 | CN1985848A Compound vitamin and mineral preparation for prenatal taking |
| 06/27/2007 | CN1985845A Oral antilipemic liquid and its preparing method |
| 06/27/2007 | CN1985836A Medicine composition for treating cerebral ischemia |
| 06/27/2007 | CN1985664A Double egg white food for teenage and its making process |
| 06/27/2007 | CN1985621A Bioactive peptide pre-mixing material and its use |
| 06/27/2007 | CN1322860C Levo carnitine dropping pill and preparation thereof |
| 06/26/2007 | US7235635 IRAK-4: compositions and methods of use |
| 06/26/2007 | US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
| 06/26/2007 | US7235628 Analogues of GLP-1 |
| 06/26/2007 | US7235572 Thiazolyl-indole derivatives, their manufacture and use as pharmaceutical agents |
| 06/26/2007 | US7235566 Pyridinone derivatives for treatment of atherosclerosis |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235555 Indolylmaleimide derivatives |
| 06/26/2007 | US7235554 Water soluble; treating diseases in which peripheral benzodiazepine receptors are involved such as spinal amyotrophy, amyotrophic lateral sclerosis, cranial and medullar trauma, multiple sclerosis, and diabetic nephropathy |
| 06/26/2007 | US7235552 Cholenic acid amides and pharmaceutical compositions thereof |
| 06/26/2007 | US7235550 Polycyclic azaindole compounds |
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides |
| 06/26/2007 | US7235543 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 06/26/2007 | US7235538 Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV |
| 06/26/2007 | US7235525 administering an effective amount of erythropoietin for treatment to a patient with renal failure-associated osteodystrophy or renal failure-associated osteoporosis |
| 06/26/2007 | US7235390 Mixture of Aspergillus derived protease, lipase, amylase and cellulase, and calcium, zinc, manganese, and magnesium cofactors; improved digestion |
| 06/26/2007 | US7235260 Pharmaceutical compositions of a sparingly soluble glycogen phosphorylase inhibitor |
| 06/26/2007 | US7235256 administering a lactating animal during dry period, in a suitable form for peroral administration, a calcium-binding compound such as polysaccharide, effective to reduce the absorption of calcium from the drinking water and/or from the ration of such animal; natural calcium regulating mechanisms |
| 06/26/2007 | CA2307792C Method for regulating size and growth of vascularized normal tissue |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/26/2007 | CA2216704C Novel peptides and remedy for bone diseases containing the same as active ingredient |
| 06/21/2007 | WO2007070796A1 Azepinoindole derivatives as pharmaceutical agents |
| 06/21/2007 | WO2007070667A2 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof |
| 06/21/2007 | WO2007070506A2 Diaza heterocyclic sulfonamide derivatives and their uses |
| 06/21/2007 | WO2007069977A1 Alkylsulphonamide quinolines |
| 06/21/2007 | WO2007069934A1 Method of treating metabolic syndrome |
| 06/21/2007 | WO2007069933A1 Method for decreasing postprandial glucose excursion |
| 06/21/2007 | WO2007069758A1 Composition having ppar ligand activity |
| 06/21/2007 | WO2007069744A1 Composition for prevention/amelioration of metabolic syndrome |
| 06/21/2007 | WO2007069716A1 Composition having effect of inhibiting visceral fat accumulation |
| 06/21/2007 | WO2007069712A1 Amine compound and use thereof for medical purposes |
| 06/21/2007 | WO2007069669A1 Pharmaceutical composition for enhancing adiponectin production |
| 06/21/2007 | WO2007069635A1 Vla-4 inhibitory drug |
| 06/21/2007 | WO2007068829A1 Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine |
| 06/21/2007 | WO2007068757A1 Food supplement based on group b vitamins, trace elements and w-3 and/or w-6 fatty acids and use of this food supplement in the simultaneous treatment of localized cellulite and slackening of the skin |
| 06/21/2007 | WO2007068641A1 Pyrrolo [2 , 3-b] pyridine derivatives as h3 receptor modulators |
| 06/21/2007 | WO2007068620A1 Pyrrolo[2,3-c]pyridine derivatives |
| 06/21/2007 | WO2007068330A1 2-ADAMANTYLUREA DERIVATIVES AS SELECTIVE 11β-HSD1 INHIBITORS |
| 06/21/2007 | WO2007068116A1 Method for correcting a lipid imbalance in a subject |
| 06/21/2007 | WO2007068076A1 Chitin derivatives for hyperlipidemia |
| 06/21/2007 | WO2007068053A1 Recombinant protein production |
| 06/21/2007 | WO2007068039A1 Treatment of weight gain in estrogen deficient mammals |
| 06/21/2007 | WO2007051134A3 Compositions and methods for increasing lean muscle mass and/or reducing fat gain |
| 06/21/2007 | WO2007050697A3 Compositions and methods for the administration psychotropic drugs which modulate body weight |
| 06/21/2007 | WO2007048841A3 Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 06/21/2007 | WO2007030567A3 Pparactive compounds |
| 06/21/2007 | WO2007003604A3 Hists1mine h3 receptor antagonists |
| 06/21/2007 | WO2006099942A3 Use of amino-substituted benzimidazoles |
| 06/21/2007 | WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
| 06/21/2007 | US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 06/21/2007 | US20070142465 Macrophage activation inhibitor |
| 06/21/2007 | US20070142449 Angiogenesis inhibitors |
| 06/21/2007 | US20070142427 Noncyclic 1,3-Dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 06/21/2007 | US20070142420 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 06/21/2007 | US20070142408 Compositions and methods for inhibiting TGF-Beta |
| 06/21/2007 | US20070142381 Calcium receptor modulating agents |
| 06/21/2007 | US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity |
| 06/21/2007 | US20070142340 Steroids as agonists for FXR |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142298 Tetrapeptide lysyl-glutamyl-aspartyl-tryp-tophane |
| 06/21/2007 | US20070142291 Methods for treating irritable bowel syndrome |
| 06/21/2007 | US20070142274 Fish protein hydrolyzate |
| 06/21/2007 | US20070141949 Aggregate of eyeballs of crustaceans, method for using the same, food containing the same and process for producing the same |
| 06/21/2007 | US20070141184 Composition for oral administration containing capsaicinoids |
| 06/21/2007 | US20070141173 Medicament comprising noble metal fine particles |
| 06/21/2007 | US20070141154 Antidiabetic formulation and method |
| 06/21/2007 | US20070141083 Use of a single-cell protein material |
| 06/21/2007 | US20070141000 e.g. L-Ascorbic acid-2-phosphoric acid-6-(2'-hexyldecanoate) sodium salt; collagen production accelerators; skin whitening; medical, pharmaceutical preparations, feeds, foods and agrochemicals; storage stability, |
| 06/21/2007 | US20070140987 Promoting whole body health |
| 06/21/2007 | US20070140984 Functional powdery product |
| 06/21/2007 | DE60121550T2 Pyrimidin-4-onderivat als LDL-PLA2 Inhibitor Pyrimidin-4-one derivative as LDL-PLA2 inhibitor |
| 06/21/2007 | DE102005061329A1 Mittel zur Anwendung bei Blutzuckerstoffwechselstörungen einschließlich Diabetes Means for use in blood sugar metabolism disorders including diabetes |
| 06/21/2007 | CA2667091A1 Method for correcting a lipid imbalance in a subject |
| 06/21/2007 | CA2633374A1 Amine compound and use thereof for medical purposes |
| 06/21/2007 | CA2633268A1 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof |
| 06/21/2007 | CA2633243A1 Azepinoindole derivatives as pharmaceutical agents |
| 06/21/2007 | CA2633186A1 2-adamantylurea derivatives as selective 11.beta.-hsd1 inhibitors |
| 06/21/2007 | CA2633129A1 Alkylsulphonamide quinolines |
| 06/21/2007 | CA2632027A1 Diaza heterocyclic sulfonamide derivatives and their uses |
| 06/21/2007 | CA2631891A1 Chitin derivatives for hyperlipidemia |
| 06/21/2007 | CA2631695A1 Pyrrolo[2,3-b]pyridine derivatives as h3 receptor modulators |
| 06/21/2007 | CA2631694A1 Pyrrolo[2,3-c]pyridine derivatives |
| 06/20/2007 | EP1798221A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 06/20/2007 | EP1797902A2 Particles for inhalation having sustained release properties |
| 06/20/2007 | EP1797898A1 Preventive/therapeutic drug for arteriosclerosis |